Dr. Evan Cole Lewis is a Pediatric Neurologist and Clinical Neurophysiologist with expertise in epilepsy, epilepsy surgery, electroencephalography (EEG), teleneurology and medical cannabis for the treatment of neurologic disorders. Dr. Lewis is the director of the Neurology Centre of Toronto (NCT) which he established in January 2017. At NCT, Dr. Lewis treats children with a variety of neurological disorders and he also treats adults for concussion, headache and epilepsy.
Dr. Lewis’ interest in medical cannabis began in 2013 while training at Miami Children’s Hospital – one of the major sites for the Epidiolex trials. He has significant clinical experience with medical cannabis in adults and children and is a member of the Canadian Consortium for the Investigation of Cannabinoids (CCIC), Canadian Childhood Cannabinoid Clinical Trials (C4T), and the Cannabinoid Research Initiative of Saskatchewan (CRIS).
Dr. Lewis attained his MD from the University of Ottawa, and trained as a Pediatric Neurologist at the Children’s Hospital of Eastern Ontario (CHEO). He completed fellowships in both clinical neurophysiology and epilepsy at Nicklaus Children’s Hospital (formerly known as Miami Children’s Hospital) and the Hospital for Sick Children. Dr. Lewis was a staff neurologist, clinical neurophysiologist and the Director of the Epilepsy Fellowship Training Program at the Hospital for Sick Children between 2015 and 2016. He also held a staff position as the primary neurologist for the Early Care Concussion Clinic at Holland Bloorview Kids Rehabilitation Hospital from 2016 – 2018.
Dr. Lewis is an Adjunct Assistant Professor at the University of Toronto, a Fellow of the Royal College of Physicians of Canada and was the Tariff Chair of the Neurology Section for the Ontario Medical Association from 2017 – 2019. He sits on the Editorial Board for the Journal of Child Neurology’s Resident/Fellow Section and is an ad-hoc reviewer for the Canadian Journal of Neurological Sciences and Paediatrics & Child Health. His research and special interests include cannabinoids in the treatment of epilepsy and other neurological conditions, concussion, epilepsy, headache and teleneurology. Dr. Lewis is an advocate for the use of teleneurology to reach the underserved areas of Ontario.